Synopsis
Synopsis
0
VMF
0
FDF
0
Australia
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 525.1 g/mol |
---|---|
Molecular Formula | C23H33ClN6O4S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 8 |
Exact Mass | 524.1972524 g/mol |
Monoisotopic Mass | 524.1972524 g/mol |
Topological Polar Surface Area | 118 A^2 |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 854 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Vardenafil hydrochloride |
Drug Label | LEVITRA is an oral therapy for the treatment of erectile dysfunction. This monohydrochloride salt of vardenafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).Vardenafil HCl is designated... |
Active Ingredient | Vardenafil hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 5mg; 10mg; 20mg |
Market Status | Prescription |
Company | Teva Pharms |
2 of 2 | |
---|---|
Drug Name | Vardenafil hydrochloride |
Drug Label | LEVITRA is an oral therapy for the treatment of erectile dysfunction. This monohydrochloride salt of vardenafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).Vardenafil HCl is designated... |
Active Ingredient | Vardenafil hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 5mg; 10mg; 20mg |
Market Status | Prescription |
Company | Teva Pharms |
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-09-15
Pay. Date : 2015-08-21
DMF Number : 25174
Submission : 2011-08-02
Status : Active
Type : II
Certificate Number : CEP 2014-106 - Rev 02
Issue Date : 2024-05-29
Type : Chemical
Substance Number : 2782
Status : Valid
Registration Number : 231MF10080
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2019-04-03
Latest Date of Registration : --
NDC Package Code : 12658-0463
Start Marketing Date : 2003-08-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2018-10-28
Registration Number : 20181028-211-J-269
Manufacturer Name : Pharmaceutical Works Polpharma S.A.
Manufacturer Address : 19. Pelplinska Str, 83-200 Starogard Gdanski, Poland
Available Reg Filing : ASMF, CA, CN |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Century has been an API manufacturer for over 30 years & is the partner of choice for multipurpose custom manufacturing projects.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-02-20
Pay. Date : 2014-12-24
DMF Number : 28900
Submission : 2014-12-31
Status : Active
Type : II
Certificate Number : R1-CEP 2015-095 - Rev 01
Issue Date : 2023-06-26
Type : Chemical
Substance Number : 2782
Status : Valid
Registration Number : 301MF10002
Registrant's Address : Alembic Road, Vadodara 390 003, Gujarat, India
Initial Date of Registration : 2019-05-08
Latest Date of Registration : --
Date of Issue : 2022-06-17
Valid Till : 2025-07-02
Written Confirmation Number : WC-0082
Address of the Firm :
Registrant Name : M-Peak Korea Co., Ltd.
Registration Date : 2018-02-22
Registration Number : 20180222-211-J-181
Manufacturer Name : Alembic Pharmaceuticals Limited (API Unit-III)
Manufacturer Address : Plot No. 842-843, Taluka-Padra, City : Karakhadi - 391 450, District-Vadodara Gujarat State, India
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-01-05
Pay. Date : 2016-10-03
DMF Number : 30804
Submission : 2016-10-27
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-09-13
Pay. Date : 2013-07-10
DMF Number : 25795
Submission : 2012-04-09
Status : Active
Type : II
Certificate Number : R1-CEP 2015-207 - Rev 00
Issue Date : 2021-09-21
Type : Chemical
Substance Number : 2782
Status : Valid
Date of Issue : 2020-07-22
Valid Till : 2022-07-02
Written Confirmation Number : WC-0079A1
Address of the Firm :
NDC Package Code : 33342-504
Start Marketing Date : 2016-02-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33220
Submission : 2019-03-07
Status : Active
Type : II
Date of Issue : 2022-02-02
Valid Till : 2024-06-07
Written Confirmation Number : WC-0317
Address of the Firm :
NDC Package Code : 52562-004
Start Marketing Date : 2020-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32908
Submission : 2018-09-20
Status : Active
Type : II
Certificate Number : CEP 2018-202 - Rev 01
Issue Date : 2024-04-04
Type : Chemical
Substance Number : 2782
Status : Valid
Date of Issue : 2022-07-08
Valid Till : 2025-07-21
Written Confirmation Number : WC-0373
Address of the Firm :
NDC Package Code : 67835-0014
Start Marketing Date : 2018-03-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?